Life ScienceCompany
Prime Therapeutics M&A Summary
Prime Therapeutics has acquired 1 company, including 1 in the last 5 years.
Prime Therapeutics’ largest acquisition to date was in 2022, when it acquired Magellan Rx Management for $1.4B. Prime Therapeutics has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Prime Therapeutics Business Overview
Where is Prime Therapeutics headquartered?
Prime Therapeutics is headquartered in Eagan, Minnesota.
What sector is Prime Therapeutics in?
Prime Therapeutics is a life science company.
When was Prime Therapeutics founded?
Prime Therapeutics was founded in 1987.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1
- M&A Advisors 3